Systematic Review on Challenges of Improving Diabetes Care across Africa
The systematic review I chose is titled Review of Ongoing Activities and Challenges to Improve the Care of Patients with Type 2 Diabetes across Africa and the Implications for the Future in the Journal of Frontiers in Pharmacology. It reviews information from recent articles about type 2 diabetes in Africa. This includes information about access, identification, and adherence to medicinal prescriptions (Godman et al., 2020). It also highlights the potential interventions for improved care for type 2 diabetes patients regarding current experiences and activities about the disease.
The significance of this review is to support the information that applies to evidence-based practice to control infectious disease. The review acknowledges that several activities to improve care for type 2 diabetes patients are ongoing in Africa and emphasizes the importance of such studies due to the prevalence of the problem in the continent. The value of further research in improving care for diabetes patients is also acknowledged in the review article. This article reviews information from primary sources on diabetes in African countries. The articles reviewed are of original research from other credible publications.
The examination of these studies focuses on existing interventions, challenges of type 2 diabetes management, and the meanings of these activities in the future. This objective reporting makes the review systematic; information is arranged logically, promoting the practical synthesis of ideas that relate to type 2 diabetes. Its purpose and objectives confine the evidence by the logical arrangement of ideas in sub-headings, tables, and countries. The author summarizes the most important findings of the review by discussing, deducing, and offering an appropriate recommendation.
References
Godman, B., Basu, D., Pillay, Y., Mwita, J. C., Rwegerera, G. M., Paramadhas, B. D. A., … & Sefah, I. (2020). Review of ongoing activities and challenges to improve the care of patients with Type 2 diabetes across Africa and the implications for the future. Frontiers in Pharmacology, 11.